Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00449280
Status:
COMPLETED
Last Update Posted:
2013-06-12
First Post:
2007-03-16
Brief Title:
Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies
Sponsor:
University of Chicago
Organization:
University of Chicago
Study Overview
Official Title:
A Drug Interaction Study of Sorafenib BAY 43-9006 Tosylate and Rapamycin in Patients With Advanced Malignancies
Status:
COMPLETED
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to determine whether a significant pharmacokinetic interaction exists between rapamycin and sorafenib
This study will also look at the toxicity of the combination of rapamycin and sorafenib and the antitumor activity of the combination in subjects with advanced cancers
This study will also look at the toxicity of the combination of rapamycin and sorafenib and the antitumor activity of the combination in subjects with advanced cancers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None